Insiders Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Real-time Estimate Tradegate Other stock markets 09:54:55 22/05/2024 BST			5-day change	1st Jan Change
31.93 ^EUR	-0.22%		-1.38%	+29.11%

05-20	AstraZeneca to build $1.5-bln cancer drug plant in Singapore	RE
05-15	Merck to present new oncology data	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INTERVIEW - Hiroyuki Okuzawa, CEO of Daiichi Sankyo: Confident about the future thanks to the drug pipeline	07/06/23	MT
Daiichi Sankyo Company, Limited Announces Retirement of Noritaka Uji, Outside Director	16/05/23	CI
Daiichi Sankyo Posts 8% Decline in Fiscal Nine-month Attributable Profit on Growing Expenses; Rejigs Management Structure	01/02/23	MT
Daiichi Sankyo Company, Limited Appoints Hiroyuki Okuzawa as New President & COO Effective as of April 1, 2023	31/01/23	CI
Daiichi Sankyo Company, Limited Announces Executives Retirement, Effective as of June 21, 2021	13/05/21	CI
Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D with Effect from April 1, 2021	22/02/21	CI
Daiichi Sankyo Company, Limited Appoints New Corporate Officers, Effective April 1, 2021	22/02/21	CI
Daiichi Sankyo Company, Limited Announce Board Resignations	11/05/20	CI
Daiichi Sankyo Company, Limited Announces Changes to Members of the Board and Members of the Audit and Supervisory Board	10/05/19	CI
Daiichi Sankyo Company, Limited Announces Management Changes	25/04/19	CI
Daiichi Sankyo Company, Limited Announces the Management Changes	29/03/19	CI
Daiichi Sankyo Company, Limited Announces Executive Changes	22/02/19	CI
Daiichi Sankyo Company, Limited Announces New Group Corporate Officers Effective from April 1, 2019	21/02/19	CI
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers	24/02/17	CI
Daiichi Sankyo Company, Limited Announces Executive Changes	31/01/17	CI
Daiichi Sankyo, Inc. Appoints Leigh Ann Errico as Vice President of Human Resources for the U.S. Administrative and Commercial Group	23/08/16	CI
Daiichi Sankyo Company Limited Announces Management Changes	12/05/16	CI
Daiichi Sankyo Appoints Dr. Antoine Yver as Global Head, Oncology Research and Development	11/04/16	CI
Daiichi Sankyo Company, Limited Announces Appointment of New Group Corporate Officers, Effective April 1, 2016	23/02/16	CI
Daiichi Sankyo Company, Limited Announces Executive Appointments	29/09/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Insiders

Filters